Registry of Asthma Patients Initiating DUPIXENT®
This study aims to understand how a medicine called DUPIXENT® is used for asthma in real-world situations. Researchers want to learn about the types of people who start using DUPIXENT®, including their age, background, and health history. They will also track how DUPIXENT® is used, how effective it is for asthma and other related conditions over time, and gather information about any long-term side effects. This helps doctors and patients better understand the benefits and experiences of using DUPIXENT® for asthma in daily life.
At a glance
What is this study about?
This study is like taking a closer look at how a medicine called DUPIXENT® works for people with asthma in their daily lives, outside of very controlled hospital settings. Think of it as a survey gathering information from lots of different people who are starting to use DUPIXENT® for their asthma right now. Doctors and researchers want to understand who these patients are, what their asthma is like, and what other health issues they might have.
The main goal is to see how different people use DUPIXENT® and how it helps them over a longer period. They'll be looking at things like whether people's asthma symptoms get better, and if other related conditions also improve. They will also keep an eye on how safe the medication is when used by many different people over time.
By collecting this information over three years, this study will give us a much clearer picture of DUPIXENT®'s effects in the real world. This helps doctors make more informed decisions and helps other patients understand what they might expect if they start using DUPIXENT® for their asthma.
Key takeaways
- This study tracks how DUPIXENT® is used for asthma in real life.
- It aims to understand who uses DUPIXENT® and how well it works over time.
- The study lasts for three years and involves regular check-ups.
- It collects information on both the effectiveness and safety of DUPIXENT®.
- Participants must be 12 years or older and starting DUPIXENT® for asthma.
Who may be eligible?
To be part of this study, you need to be at least 12 years old and starting DUPIXENT® for your asthma. You should be able to attend all the necessary clinic visits and complete questionnaires about your health and how you're feeling. If you're under 18, both you and your parent or guardian will need to agree to take part.
There are a few reasons you might not be able to join. For example, if your doctor says DUPIXENT® isn't suitable for you, or if you've already used DUPIXENT® or a similar medicine in the last six months. Also, if there's any other medical condition or personal situation that might make it hard for you to complete the study visits and assessments, you might not be able to participate. Your doctor will discuss all these points with you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 12 years old or older?
- Are you about to start taking DUPIXENT® for your asthma?
- Can you attend regular appointments and fill out questionnaires?
- Have you *not* taken DUPIXENT® or similar medicines in the last 6 months?
- Do you have no medical reason that prevents you from taking DUPIXENT®?
What does participation involve?
If you decide to join this study, your journey will last for three years. You'll continue to receive DUPIXENT® as prescribed by your doctor for your asthma. Throughout these three years, you'll have regular clinic visits where you'll answer questions about your health, your asthma, and how you're feeling. You'll also complete some forms or questionnaires. These visits help the researchers understand how DUPIXENT® is working for you and collect important information over time. The study doesn't involve any new or different treatments beyond what your doctor would normally prescribe.
Potential risks and benefits
Locations (128)
- Clinical Research Center of Alabama, LLCVerified postcodeBirmingham, United States
- Arizona Allergy & Immunology ResearchVerified postcodeGilbert, United States
- Medical Research of Arizona, a Division of Allergy, Asthma & Immunology Associates, Ltd.Verified postcodeScottsdale, United States
- Children's Hospital of Orange CountyVerified postcodeOrange, United States
- Riviera Allergy Medical CenterVerified postcodeRedondo Beach, United States
- Allergy & Asthma Medical Group and Research, A PCVerified postcodeSan Diego, United States
- Bensch Clinical Research, LLCVerified postcodeStockton, United States
- Allianz Research Institute, Inc.Verified postcodeWestminster, United States
- Global Research SolutionsVerified postcodeHollywood, United States
- Memorial Healthcare SystemVerified postcodeHollywood, United States
- Clinical Research Specialists, LLCVerified postcodeKissimmee, United States
- Kratz Allergy & AsthmaVerified postcodePort Richey, United States
Common questions
What is DUPIXENT®?
DUPIXENT® is a medicine used to treat certain types of asthma.
How long will the study last?
The study will last for three years for each person participating.
Will I get DUPIXENT® as part of this study?
Yes, you will continue to use DUPIXENT® for your asthma as prescribed by your doctor during the study.
Do I have to take part?
No, taking part is completely voluntary, and you can change your mind at any time.
Will my information be kept private?
Yes, all your personal and health information will be kept confidential.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.